title: [Antibiotic treatment of lung disease in cystic fibrosis].
abstract: Patients suffering from chronic lung infections are a major problems in therapy of cystic fibrosis (CF). Resistance frequently occurs with great rapidity among isolates of Staphylococcus aureus and Pseudomonal aeruginosa. The rational for the use of frequent antibiotics (reduction of bacterial count), and the principle to follow while using antibiotics in CF patients are discussed. Research on amikacin peak levels and its average levels in serum, saliva and sputum is presented.
mesh_terms: D000583:Amikacin / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014018:Tissue Distribution
chemical_list: D000900:Anti-Bacterial Agents; D000583:Amikacin
vernacular_title: Il trattamento antibiotico della pneumopatia nella fibrosi cistica.